Agentix (AGTX) Assets Growth (1y) (2015 - 2026)
Agentix (AGTX) Assets Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99.14% |
| Mar 31, 2026 | -99.23% |
| Dec 31, 2025 | -95.85% |
| Sep 30, 2025 | -96.70% |
| Jun 30, 2025 | -97.36% |
| Mar 31, 2025 | -5.73% |
| Dec 31, 2024 | 37.66% |
| Sep 30, 2024 | -49.07% |
| Jun 30, 2024 | -49.49% |
| Mar 31, 2024 | -59.31% |
| Dec 31, 2023 | 0.43% |
| Sep 30, 2023 | 3,809.83% |
| Jun 30, 2023 | 2,898.55% |
| Feb 28, 2022 | 33.18% |
| Nov 30, 2021 | -17.04% |
| Aug 31, 2021 | -82.51% |
| May 31, 2021 | 339,947.06% |
| Feb 28, 2021 | 391,000.00% |
| Nov 30, 2020 | 100,044.26% |
| Aug 31, 2020 | 314,684.95% |